GlassScriptPhysician profile
Kashif Ashfaq
NPI 1861649303
$12,662.29
in general payments reported to CMS, 2019-2025
13 companies · $2,400 in 2025
The $2,400 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.08 · 2020: $130 · 2021: $4,403 · 2022: $2,255 · 2023: $151 · 2024: $3,298 · 2025: $2,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,121 · Food and Beverage: $1,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,121.41 |
| Food and Beverage | $1,727.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $7,767.03 | 2022-2025 | Oxford, Persona |
| Arthrex, INC. | $2,810.68 | 2021 | |
| Titan Surgical Group, LLC | $1,525.26 | 2021 | |
| Stryker Corporation | $117.26 | 2019-2020 | |
| Medacta USA, INC. | $105.01 | 2023 | Amistem |
| Smith+Nephew, INC. | $103.01 | 2020-2025 | Legion Revision, Tandem, Real Intelligence |
| Pacira Pharmaceuticals Incorporated | $52.44 | 2021-2024 | Iovera, Zilretta, Exparel |
| Orthalign INC | $52.44 | 2025 | Orthalign Plus |
| Encore Medical, LP | $45.99 | 2023 | Djo Surgical |
| Amgen INC. | $32.52 | 2022 | |
| Innovation Technologies INC | $21.53 | 2021 | |
| Si-Bone, INC. | $15.58 | 2021 | |
| Depuy Synthes Sales INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kashif Ashfaq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.